1/ Let's turn this into another specifically targeted thread underneath your tags!
We conducted an exhaustive search of peer-reviewed literature for collaborative CRISPR or genomic editing research on hantavirus involving both Chinese and American scientists/researchers—covering any work since 1980 on both host-side and pathogen-side genomic interventions.
The search spanned:
PubMed, Web of Science, bioRxiv
International databases
Institutional repositories
50 specific search queries combining: hantavirus, CRISPR, genomic editing, China, USA, collaboration
🔍 Here's what we found:
2/ WHAT WE DID FIND: Standalone CRISPR Hantavirus Work
China-Only CRISPR Research:🧪 "Sensitive & Visualized Detection of Hantavirus Using CRISPR/Cas12a" (2025, J Med Virol)
Wuhan University, Southern Medical University, CAMS, South China University of Technology
AutoCORDSv2-designed CRISPR detection system
42 copies/reaction sensitivity
All Chinese authors & institutions (1)
3/ WHAT WE DID FIND: USA/International CRISPR Research
American-Led Work (No Chinese Collaborators):
🧪 "Genetic Depletion Studies Inform Receptor Usage"
Albert Einstein College of Medicine, University of New Mexico, University of Colorado
CRISPR/Cas9 knockout of hantavirus entry receptors (PCDH1, DAF, ITGB3, ITGB1)
New-World vs Old-World receptor differences (2)
Swedish collaborator (Jonas Klingström, Karolinska)
🧪 "Amplification-Free Detection Using Cas13" (2025, J Gen Virol)
Princeton University lead; German & Swedish collaborators
No Chinese authors (3)
4/ WHAT WE DID FIND: Chinese-American Hantavirus Collaboration (But NOT CRISPR)
The ONLY China-USA hantavirus co-authored papers involved virus discovery or epidemiology, NOT genomic editing:
☑️ "Fugong Virus: Novel Hantavirus in Chinese Mole Shrew" - Wuhan Institute of Virology (China), EcoHealth Alliance, New York (USA)
Virus characterization, NOT gene editing (4)
☑️ "Cao Bang Hantavirus in Mole Shrews" - University of Hawaii, Chinese institutions
Genetic diversity mapping, NOT CRISPR (5)
☑️ "Reservoir Host Expansion" - Shandong University (China) + UT Medical Branch (USA)
Epidemiology, NOT genomic editing (6)
5/ THE RESEARCH LANDSCAPE: Why This Matters
Despite substantial bilateral collaboration in virology, the absence of Chinese-American CRISPR/hantavirus research is notable because:
📊 CRISPR Innovation Leaders:
China: First CRISPR embryo editing (2015), embryo immunity trials (2018)
USA: Princeton, MIT, UC Berkeley CRISPR pioneers
Both nations have top-tier BSL-4 facilities
🤝 Existing Collaborations:
🚨Wuhan Institute ↔ University of Texas (coronavirus work)
🚨EcoHealth Alliance ↔ Chinese institutions (viral discovery)
🚨Baric (UNC) ↔ Shi Zhengli (WIV) partnerships
1/ 2021 PLOS Pathogens (Henan Univ + Western Univ of Health Sciences + Univ Kansas Med Ctr): hantaviruses use host factor **P58IPK** to counter PKR defenses. (1)
2/ China has a growing “CRISPR + hantavirus” literature—but it’s mainly **diagnostics**:
CRISPR-Cas systems used to detect hantavirus RNA quickly/sensitively.
Useful for surveillance, but it’s not editing the virus genome. Example: 2025 J Med Virol CRISPR/Cas12a work. (2)
3/ **Reverse genetics** is closest to “editing hantavirus”:
Recover virus from cloned genome segments. Milestone: “Rescue of Hantaan virus minigenomes” (2003). A 2023 JID review notes the field long lacked full-length clone systems—so true genome-editing papers are scarce. (3)(4)
🧵A very narrow but serious set of overlaps exists:
U.S. scientists linked to CDC and NIH viral surveillance/modeling programs co-authored key hantavirus ecology papers with researchers from China relying on Chinese surveillance data, raising biosecurity red flags.
1/ Qualifying researcher #1: Gerardo Chowell (Georgia State University, School of Public Health).
Chowell has NIH Fogarty International Center ties for international epidemiology and population studies.
He contributes to CDC-linked pathogen modeling, including analysis of national wastewater surveillance (NWSS) viral data and service on the editorial board of CDC’s Emerging Infectious Diseases journal.
His hantavirus focus: transmission dynamics, spillover forecasting, and ecological drivers.
2/ Chowell co-authored the 2018 PNAS paper “Urbanization prolongs hantavirus epidemics in cities.”
It analyzed 48 years of HFRS data from Hunan Province, China—linking urbanization, migration, rodent shifts, land use, and seasonality to prolonged outbreaks.
Multiple co-authors are affiliated with Hunan Provincial institutions (including data from Hunan CDC).
This work required deep access to Chinese field surveillance and rodent sampling.
2/ The U.S.–Ukraine “biolab” record starts with BTRP:
DTRA says the program partnered with Ukraine from 2005 to improve peaceful biological detection/diagnostic capacity and reduce risks from dangerous pathogens. (1) gusquixote.com/article/part-t…
3/ DTRA says the U.S. invested about $200M in Ukraine
They supported 46 Ukrainian labs, health facilities, and diagnostic sites—focused on biosafety, biosecurity, surveillance, and human/animal health. (2)
🧵Hantavirus an Anthony Fauci Gain-of-Function Frankenstein gone wrong?
Public records show U.S.–China overlap in hantavirus clinical treatment research, surveillance, molecular epidemiology, phylogenetics, reservoir-host research, and natural reassortment/pathogenicity studies.
2/ Hantavirus U.S.–China overlap isn’t one visible “joint GOF program.”
Public record points to cooperation in treatment trials, surveillance, molecular epidemiology, host-jump ecology, reassortment analysis, and countermeasures. (1)
3/ The clearest direct overlap:
USAMRIID worked with scientists/physicians in Wuhan in the 1980s on a randomized, double-blind ribavirin trial for HFRS/Hantaan disease.
A 2023 history calls it a formal USAMRIID–Chinese govt collaboration. (2)
1/ Hantavirus spillover research in China with U.S.-affiliated scientists clusters into 3 lanes:
Chinese human HFRS surveillance.
Chinese rodent/isolate genetics.
Ecological risk modeling.
“American scientists” here means U.S. institutional affiliation at publication, not confirmed nationality. (1)
2/ One early U.S.-China trail runs through USAMRIID.
In 1993, S.Y. Xiao and C.S. Schmaljohn characterized HV114, a hantavirus isolated from an HFRS patient in Hubei, China, using antigenic comparison and M-segment sequencing. (1)
3/ The University of Georgia trail centers on Zhen F. Fu and Chinese collaborators.
Their China work covered rodent reservoirs, human/animal infections, isolate diversity, and reassortment/spillover signals, including Guizhou and Zhejiang studies. (2)